Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Balcerzak · SciRah

Researcher profile · Semantic Scholar

S. Balcerzak

Share profile

S. Balcerzak — researcher profile on SciRah

h-index: 48
Works: 233
Citations: 9,448

Most-cited papers

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
A. Wozniak, J. Crowley, S. Balcerzak, G. Weiss +7 more
1998Journal of Clinical Oncology581 citations
Semantic Scholar
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
V. Sandor, Susan Bakke, R. Robey, M. Kang +11 more
2002Clinical Cancer Research540 citations
Semantic Scholar
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
K. Antman, J. Crowley, S. Balcerzak, S. Rivkin +6 more
1993Journal of Clinical Oncology475 citations
Semantic Scholar
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.
J. Weick, K. Kopecky, F. Appelbaum, D. Head +7 more
1996Blood436 citations
Semantic Scholar
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
J. Godwin, K. Kopecky, D. Head, C. Willman +4 more
1998Blood321 citations Open access
Semantic Scholar
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
G. Marcucci, J. Byrd, G. Dai, M. Klisovic +16 more
2003Blood224 citations
Semantic Scholar
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
M. Grever, K. Kopecky, C. Coltman, J. Files +5 more
1988Nouvelle revue francaise d'hematologie191 citations
Semantic Scholar
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.
Jeanne E. Anderson, K. Kopecky, C. Willman, D. Head +7 more
2002Blood164 citations
Semantic Scholar
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
M. Zalupski, B. Metch, S. Balcerzak, W. Fletcher +6 more
1991Journal of the National Cancer Institute158 citations
Semantic Scholar
Low-dose deoxycoformycin in lymphoid malignancy.
Michael R. Grever, J. Leiby, E. Kraut, Henry E. Wilson +3 more
1985Journal of Clinical Oncology149 citations
Semantic Scholar
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.
P. Ganz, C. Moinpour, D. Pauler, A. Kornblith +7 more
2003Journal of Clinical Oncology91 citations
Semantic Scholar
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Richard I. Fisher, B. Dana, M. LeBlanc, Carl R. Kjeldsberg +6 more
2000Journal of Clinical Oncology85 citations
Semantic Scholar
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
Laurence H. Baker, J. Frank, Gerald Fine, S. Balcerzak +5 more
1987Journal of Clinical Oncology82 citations
Semantic Scholar
5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.
G. Budd, T. R. Fleming, R. M. Bukowski, J. Mccracken +4 more
1987Journal of Clinical Oncology78 citations
Semantic Scholar
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma
Stephen Williamson, D. Lew, G. Miller, S. Balcerzak +2 more
2000Cancer71 citations
Semantic Scholar
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
M. Hussain, Tracy R. Glass, Jeffrey D. Forman, Wael A. Sakr +6 more
2001Journal of Urology69 citations
Semantic Scholar
A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study
S. Balcerzak, J. Benedetti, Geoffrey R. Weiss, R. Natale
1995Cancer64 citations Open access
Semantic Scholar
Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.
Stephen E. Jones, P. Grozea, T. P. Miller, E. J. van Slyck +6 more
1985Journal of Clinical Oncology62 citations
Semantic Scholar
Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.
S. Salmon, J. Crowley, S. Balcerzak, R. Roach +3 more
1998Journal of Clinical Oncology61 citations
Semantic Scholar
A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study
B. Zidar, S. Green, H. Pierce, R. Roach +2 more
1988Investigational new drugs58 citations
Semantic Scholar
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study
S. Petersdorf, K. Kopecky, D. Head, D. Boldt +5 more
2001Leukemia52 citations Open access
Semantic Scholar
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
W. Velasquez, D. Lew, T. Grogan, C. Harris Spiridonidis +6 more
2003Journal of Clinical Oncology50 citations
Semantic Scholar
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.
B. Dana, S. Dahlberg, Thomas P. Miller, R. Hartsock +5 more
1990Journal of Clinical Oncology50 citations
Semantic Scholar
A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group study.
J. Hewlett, K. Kopecky, D. Head, H. Eyre +6 more
1995Leukemia47 citations
Semantic Scholar
Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.
F. Meyskens, P.-Y. Liu, Ralph J. Tuthill, Vernon K. Sondak +6 more
1994Journal of Clinical Oncology46 citations
Semantic Scholar
Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.
J. Weick, S. Dahlberg, R. Fisher, B. Dana +3 more
1991Journal of Clinical Oncology43 citations
Semantic Scholar
Phase II Evaluation of Recombinant Interferon-β (LFN-βser) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group Study
D. V. Von Hoff, B. Metch, J. Lucas, S. Balcerzak +2 more
199043 citations
Semantic Scholar
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
P. Hesketh, J. Crowley, H. Burris, S. Williamson +7 more
1999The cancer journal from Scientific American40 citations
Semantic Scholar
A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma
Karen H. Antman, J. Crowley, S. Balcerzak, Raymond A. Kempf +3 more
1998Cancer39 citations
Semantic Scholar
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study
B. Zidar, B. Metch, S. Balcerzak, H. Pierce +3 more
1992Cancer39 citations Open access
Semantic Scholar
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs.
D. Unverferth, C. Leier, S. Balcerzak, R. L. Hamlin
1985American Journal of Cardiology39 citations
Semantic Scholar
Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial.
F. Meyskens, K. Kopecky, F. Appelbaum, S. Balcerzak +2 more
1995Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis34 citations Open access
Semantic Scholar
Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck
D. Mattox, D. V. Von Hoff, S. Balcerzak
2004Investigational new drugs33 citations
Semantic Scholar
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.
F. Morrison, K. Kopecky, D. Head, J. Athens +6 more
1992Leukemia33 citations
Semantic Scholar
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
S. Petersdorf, C. Rankin, David R. Head, H. Terebelo +5 more
2007American journal of hematology/oncology31 citations Open access
Semantic Scholar
Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.
E. Gaynor, J. M. Unger, T. Miller, T. M. Grogan +6 more
2001Journal of Clinical Oncology31 citations
Semantic Scholar
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
M. von Mehren, S. Balcerzak, A. Kraft, J. Edmonson +5 more
2004Sarcoma30 citations
Semantic Scholar
Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients
Jing Liu, E. Kraut, J. Bender, R. Brooks +6 more
2002Cancer Chemotherapy and Pharmacology30 citations
Semantic Scholar
NCCN Sarcoma Practice Guidelines
G. Demetri, R. Pollock, L. Baker, S. Balcerzak +7 more
199829 citations
Semantic Scholar
Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.
Oliver W. Press, M. LeBlanc, T. O'Rourke, Suzanne Gagnet +3 more
1998Journal of Clinical Oncology27 citations
Semantic Scholar
A comprehensive phase I and II clinical investigation of fludarabine phosphate.
M. Grever, J. Leiby, E. Kraut, E. Metz +3 more
1990Seminars in Oncology23 citations
Semantic Scholar
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck
D. Mattox, G. Clark, S. Balcerzak, R. O'Bryan +2 more
2004Investigational new drugs22 citations
Semantic Scholar
Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group Study.
Anwar N. Mohamed, M. Zalupski, J. Ryan, Fred Koppitch +3 more
1997Cancer Genetics and Cytogenetics22 citations
Semantic Scholar
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study.
B. Tranum, D. Dixon, J. Quagliana, J. Neidhart +6 more
1987Cancer treatment reports22 citations
Semantic Scholar
Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: A Southwest Oncology Group study
J. Cowan, S. Green, J. Lucas, J. Weick +4 more
1988Investigational new drugs20 citations
Semantic Scholar
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide – a Southwest Oncology Group clinical and pharmacokinetic study
S. Grunberg, J. Crowley, K. Hande, D. Giroux +7 more
1999Cancer Chemotherapy and Pharmacology19 citations
Semantic Scholar
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.
J. Welborn, K. Kopecky, Frederick J. Meyers, R. Veith +4 more
1995Leukemia19 citations
Semantic Scholar
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat
Jing Liu, E. Kraut, S. Balcerzak, M. Grever +2 more
2002Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
Mitoxantrone hydrochloride (NSC-310739) in lymphoma
C. Coltman, T. M. McDaniel, S. Balcerzak, F. Morrison +1 more
2004Investigational new drugs16 citations
Semantic Scholar
A Phase II Study of 9-Aminocamptothecin in Patients with Refractory Breast Cancer
E. Kraut, S. Balcerzak, Donn Young, M. O'Rourke +3 more
2000Cancer Investigation16 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kopecky×9
Invite
K. Kopecky — researcher profile on SciRah
S. Rivkin×6
Invite
S. Rivkin — researcher profile on SciRah
E. Kraut×6
Invite
E. Kraut — researcher profile on SciRah
C. Coltman×5
Invite
C. Coltman — researcher profile on SciRah

×4

Invite

J. Crowley — researcher profile on SciRah

Invite

L. Baker — researcher profile on SciRah

Kenneth K. Chan×4

Invite

Kenneth K. Chan — researcher profile on SciRah

F. Appelbaum×4

Invite

F. Appelbaum — researcher profile on SciRah

Invite

M. Grever — researcher profile on SciRah

Richard I. Fisher×4

Invite

Richard I. Fisher — researcher profile on SciRah

Thomas P. Miller×4

Invite

Thomas P. Miller — researcher profile on SciRah

Invite

G. Weiss — researcher profile on SciRah